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Copyright © 2008 AHC The distribution of histo-blood group A type 1, 2 and 3 antigens was investigated using im-
munohistochemistry in normal human skin and extramammary Paget’s disease (EMPD). We
used monoclonal antibodies (mAbs) Bioclone-A (BA) and AR-1, which react with histo-blood
group A type 1/2, and type 3 antigens, respectively. We found that A type 1, 2 and 3 anti-
gens were expressed in the upper layer of the epidermis. We also found that the duct cells
of the eccrine glands expressed A type 1/2 antigens and A type 3 antigens regardless of
secretor status. The dark cells of the eccrine glands expressed A type 1, 2 and 3 antigens
from A blood group secretors, but not from non-secretors. Apocrine glands, hair follicles and
sebaceous glands did not express these antigens. Since these antigens were localized in
the eccrine glands, we examined the possibility of a skin tumor marker. Interestingly, 7 out
of 16 extramammary Paget’s disease cases were immunopositive for these antigens. Six
cases were accompanied by dermal invasion. Five cases without dermal invasion were im-
munonegative against these antigens. These results suggest that the expression of histo-
blood group A antigens in EMPD are associated with a poor histopathological prognosis.
Key words: histo-blood group A type 1/2 antigens, histo-blood group A type 3 antigens, eccrine
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I. Introduction
The ABH determinants are oligosaccharides composed
of L-fucose, D-galactose, and D-N-acetylgalactosamine [5,
31]. Clausen and Hakomori [3] proposed the concept of an
inner and a peripheral core in these oligosaccharides. The
core extending from the glycosylation site is designated as
the inner core, while the peripheral disaccharides, which
serve as the actual precursor structures for various glycosyl-
transferases, are designated as the peripheral core. Most of
the blood group-related transferases, which terminate the
chain elongation process, are among the precursor structures
included in the peripheral core. It is thus well known that the
antigenicity of the ABH determinants is influenced by the
peripheral core structure. There are four types of peripheral
core structures known to carry ABH activity: type 1:
Galβ1→3GlcNAcβ1→R, type 2: Galβ1→4GlcNAcβ1→R,
type 3: Galβ1→3GalNAcα1→R, and type 4: Galβ1
→3GalNAcβ1→R [3]. The peripheral core disaccharides
are differentially distributed onto various human tissues
and body fluids. Type 1 antigens are widely expressed on
endodermally-derived tissues such as lining epithelia and
glandular epithelia. Type 2 antigens are found mainly on
ecto- or mesodermally-derived tissues, including erythro-
cytes [17]. Type 3 and 4 antigens are found on ecto- or endo-
dermally-derived tissues, including the salivary glands and
kidneys [3]. Thus, ABH antigens are present not only on
erythrocytes, but also on various organs such as the salivary
glands and kidneys [1, 9], hence they are called histo-blood
group ABH antigens.
Interestingly, these antigens are seen in the normal
epidermis and in the epidermal appendages [10, 16, 32].
England et al. [10] found that isoantigens A, B, and H (O)
were detected in the stratum corneum, stratum granulosum,
stratum spinosum, acrosyringium, keratogenous zone of
hair follicle, eccrine duct and eccrine gland.Tanaka et al. 166
On the other hand, the alteration of cell-surface blood
group antigens during malignant transformation is a well-
known phenomenon observed in various tumor conditions
[6, 14, 22]. This occurs in carcinomas of the oral epithelium
[4], the stomach [11], the colon [11, 25], the pancreas [7,
12], the lung [24], the urinary bladder [21] and the thyroid
glands [12]. To the best of our knowledge, this phenomenon
has not been investigated in extramammary Paget’s disease
(EMPD).
In this study, we investigated the immunohistochemical
distribution of peripheral core isotypes of histo-blood group
antigens in normal human skin and EMPD to assess the
usefulness of the altered expression of histo-blood group
antigens for the diagnosis and prognosis of EMPD.
II. Materials and Methods
Specimens
Normal skin samples consisted of 11 patients (individ-
ual age ranged from 0 to 87, mean age: 46.9 years, male to
female ratio: 3:8). The samples from O and B blood group
individuals were used as negative controls.
Neoplastic samples were selected from routine speci-
mens of 16 patients seen in our hospital from 1984 to 2006.
These tissues were obtained from skin biopsies or surgery.
The individual ages ranged from 59 to 88 (mean age: 76
years, male to female ratio: 11:5). The blood groups of these
samples were either A or AB. All specimens were fixed in
4% buffered formaldehyde, and the paraffin-embedded sec-
tions were stained with hematoxylin-eosin (HE). All neo-
plasms were histopathologically diagnosed by at least 3
dermatologists or pathologists, and were divided into five
groups using the pT classification according to the tentative
classification system proposed by the Japanese Skin Cancer
Society [23]. A secretor is defined as a person who secretes
their histo-blood group antigens into their body fluids and
secretions, and is under the control of the secretor (Se) gene-
encoded α1,2-fucosyltransferase (FUT II). A non-secretor is
defined as a person who does not express functional FUT II,
and does not secrete their histo-blood group antigens into
their body fluids or secretions. Secretor status was deter-
mined by staining of the eccrine glands using immuno-
histochemistry. Those samples in which both duct cells and
dark cells of the eccrine glands were immunostained were
designated as secretors. Those samples in which only duct
cells were immunostained were designated as non-secretors.
This study was approved by the ethics committee of
Wakayama Medical University.
Antibodies
The mouse monoclonal antibody (mAb) directed
against A type 3 antigens (AR-1: IgM) was produced as de-
scribed previously [20]. The specificity of AR-1 was deter-
mined by thin layer chromatographic-immunostaining of
glycosphingolipids extracted from blood group A erythro-
cyte membranes. Their specificity was confirmed through
comparison with authentic anti-type 3 A mAb TH-1 [2].
MAb Bioclone Anti-A (BA) was purchased from Ortho
Clinical Diagnosis (Raritan, NJ). MAb AR-1 was then eval-
uated and used on the type 3 peripheral core isotypes, and
mAb BA was evaluated and used on the type 1/2 peripheral
core isotypes.
Anti-human milk fat globule 1 (anti-HMFG1) antibody
(clone 1.10.F3), a marker for apocrine differentiation, was
purchased from Abcam (Cambridge, MA).
Tissue processing
The specimens were fixed in formaldehyde for routine
histopathology. Six-μm sections were deparaffinized, im-
mersed in 3% H2O2 for 5 min, and incubated with each mAb
(AR-1, 1:20; BA, 1:100 and anti-HMFG1, 1:20) for 60 min
at room temperature (RT) after rinsing with PBS. Sections
were incubated with goat anti-mouse immunoglobulins
conjugated to a peroxidase labeled dextran polymer
(EnVision+TM, Dako Cytomation, Kyoto, Japan) for 30
min at RT. Positive reactions were then visualized with 3-
amino-9-ethylcarbazole, and counterstained with Mayer’s
hematoxylin.
The blood group-specific reactivity of mAb BA and
AR-1 was confirmed by the absorption of antibodies with
excess amounts of A or O blood group red cells, as described
previously [20].
The stained specimens were evaluated by three blinded
investigators without prior knowledge of the clinical data of
the patients.
Statistical analysis
The samples were histopathologically divided into two
groups, non-invasive and invasive, according to the pT clas-
sification [23]. T1 (where the neoplastic cells are located in
the epidermis) is defined as non-invasive, whereas T2
(where the neoplastic cells are located in the dermis associ-
ated with microinvasion), T3 (where the neoplasm forms
nodules without vessel invasion) and T4 (where the neo-
plasm forms nodules with vessel invasion) are defined as
invasive. The 2×2 cross-categorized frequency data were
analyzed using Fisher’s exact test. We evaluated the
Table 1. Expression of A type 1, 2 and 3 antigens in the appendages
+*: detected only from secretor individuals.
AR-1 BA
eccrine glands intraepidermal duct cells + +
intradermal duct cells + +
secretory cells
dark cells +* +*
clear cells – –
luminal secretions +* +*
apocrine glands duct cells – –
secretory cells – –
luminal secretions – –
sebaceous glands – –
hair follicle – –Expression of Histo-Blood Group Antigens 167
relationship between histo-blood group antigen expression
and the non-invasive and invasive groups using the online
facility at http://faculty.vassar.edu/lowry/VassarStats.html.
A P<0.05 was considered to be statistically significant.
III. Results
Localization of peripheral core-isotypes of histo-blood group 
antigens in normal skin
In the normal skin tissues, the localization of A type 1/
2 antigens as defined by mAb BA and A type 3 antigens as
defined by mAb AR-1 was investigated immunohistochem-
ically, and the results are summarized in Table 1. The upper
layer of the epidermis expressed A type 1/2 antigens
(Fig. 1A, E) and A type 3 antigens (Fig. 1B, G). The duct
cells of the eccrine glands expressed A type 1/2 antigens
(Fig. 1C, F, I) and A type 3 antigens (Fig. 1D, H, K) regard-
less of their secretor status. The dark cells of the eccrine
glands expressed A type 1/2 antigens (Fig. 1C, J), and 3
antigens (Fig. 1D, L) from A blood group secretors but not
from non-secretors (Fig. 1F, H). Duct cells positive for A
type 1/2 antigens and A type 3 antigens showed circumfer-
ential luminal immunostaining (Fig. 1C, D, F, H, I, K). Dark
cells positive for A type 1, 2 and 3 antigens showed diffuse
Fig. 1. Sections from blood group A non-secretor (A and B) and secretor individuals (C and D) were immunostained by mAb BA (A and C) or
AR-1 (B and D). In the specimen from the non-secretor (A), A type 1/2 antigens as defined by mAb BA were expressed in the upper layer of the
epidermis (E) and the duct cells of the inner layer of the eccrine glands (F; arrows), but not in the dark cells (F; closed arrowheads). In the spec-
imen from the secretor (C), A type 1/2 antigens were localized in the dark cells (C; closed arrowheads) and duct cells (C; arrows). Areas indi-
cated by the boxes (E, F, I and J) in A and C are depicted at a higher magnification in E, F, I and J, respectively. In the specimen from the non-
secretor (B), A type 3 antigens as defined by mAb AR-1 were also expressed in the upper layer of the epidermis (G) and the duct cells of the
eccrine glands (H; arrows), but not in the dark cells (H; closed arrowheads). In the specimen from the secretor (D), A type 3 antigens were
localized in the dark cells (D; closed arrowheads) and duct cells (D; arrows). The areas indicated by the boxes (G, H, K and L) in B and D are
depicted at a higher magnification in G, H, K and L, respectively. Hair follicles (A, B; arrows) and sebaceous glands (B; closed arrowhead)
were immunonegative. Note that strong immunostaining was observed in the luminal cells of the eccrine duct (C, D, F, H: arrows, I, K).
Bars=500 µm (A and B), 50 µm (C–H), 15 µm (I–L), and 200 µm (M).Tanaka et al. 168
cytoplasmic and membrane immunostaining (Fig. 1C, D, J,
L). Hair follicles and sebaceous glands did not express these
histo-blood group antigens (Fig. 1A, B). The immunostain-
ing was inhibited by the preabsorption of mAb BA and mAb
AR-1 with blood group A red cells, but not with blood group
O red cells (data not shown). Immunoreactivity was not
detected in any of the normal skin samples from O or B
individuals (data not shown). These facts confirmed the A
blood group-specific reactivity of mAb BA and mAb AR-1.
The apocrine glands expressed human milk fat globule
1 (HMFG1) (Fig. 2C). A type 1, 2 and 3 antigens were ex-
pressed only in the eccrine gland (right side, Fig. 2A, B) and
not the apocrine gland (left side, Fig. 2A, B). A type 1/2
antigens were expressed in both the blood vessels of the
stroma (Fig. 2A) and the eccrine gland (right side, Fig. 2A).
Therefore, the eccrine glands can be distinguished from
the apocrine glands by the expression of histo-blood group
antigens.
Localization of peripheral core-isotypes of histo-blood group 
antigens in extramammary Paget’s disease
We investigated the expression of peripheral core-
isotypes of histo-blood group antigens and HMFG1 in
EMPD (data summarized in Table 2). Seven (43.8%) out
of 16 EMPD cases expressed histo-blood group antigens
(Fig. 3C–F) (Table 2; Case 6 and Cases 9–14). In 6 out of 7
histo-blood group antigen positive cases, neoplasms were
located in the genital area and were accompanied by dermal
invasion. In the remaining histo-blood group antigen posi-
Fig. 2. Localization of A type 1, 2 and 3 antigens and human milk
fat globule 1 (HMFG1) in eccrine and apocrine glands. A, B and C
are serial sections from a secretor blood group AB individual. A
type 1/2 antigens (A) and A type 3 antigens (B) were expressed in
the eccrine glands (right side), whereas HMFG1 (C) was expressed
only in the apocrine glands (left side). A type 1/2 antigens were
both expressed in the blood vessels of the stroma (A). Bar=400 µm
(A–C).
Table 2. Expression of A type 1, 2 and 3 antigens and human milk
fat globule 1 in extramammary Paget’s disease patients
N/A: not applicable, s*: secretor individuals, ns**: non-secretor
individuals, +†: axillary region, +††: inguinal region. adenoid†††: neo-
plastic cells showed adenoid proliferation. Note: Cases 9–16
showed dermal invasion.
case pT 
classification
lymph node 
metastasis AR-1 BA HMFG blood 
group
secretor 
status
1T 1 N / A– – –A s *
2T 1 N / A– – + A s *
3 T1 N/A – – – AB ns**
4T 1 N / A– – –A N / A
5T 1 N / A– – –A s *
6 T1† +†† ++ + A s *
7T 1  
(adenoid†††)
N/A – – – AB ns**
8T 1  
(adenoid†††)
N/A – – – A s*
9T 2 N / A+ + + A s *
10 T2 N/A + + – A s*
11 T2 – + + – A s*
12 T2 N/A + + – A s*
13 T3 +†† ++ + A B s *
14 T4 +†† ++ + A s *
15 T4 +††, lung 
metsatasis
– – + A ns**
16 T4 – – – A s*Expression of Histo-Blood Group Antigens 169
tive case (Case 6 in Table 2), the neoplasm was located
in the axillary region. Five cases without dermal invasion
(Cases 1–5 in Table 2) were not immunoreactive to these
mAbs (Fig. 3A, B). A type 1/2 antigens and A type 3 anti-
gens were localized in the same region. We found that
histo-blood group antigens expression was significantly
associated with the invasive group (stage pT2 to pT4) as
compared with the non-invasive group (stage pT1) (p=0.04,
Fisher’s exact test).
HMFG1 and histo-blood group antigens were immuno-
positive on distinct regions in EMPD tissues (Fig. 3G).
Some neoplastic cells in EMPD expressed either histo-blood
Fig. 3. Expression of A type 1–3 and HMFG1 in extramammary Paget’s disease (EMPD). A type 1, 2 and 3 antigens were not detected in the
sections from the specimen (case 4 in Table 2) without dermal invasion by mAb BA (A) and AR-1 (B). In sections from the specimen (case 9 in
Table 2) accompanied by dermal invasion, A type 1/2 and A type 3 antigens were detected by mAb BA (C) and AR-1 (E), respectively. Arrows
in C and E indicate the regions of dermal invasion by the neoplastic cells. Areas indicated by the boxes in C and E are depicted at a higher mag-
nification in D and F, respectively. HMFG1 was localized in a different and distinct region from the histo-blood antigens in the epidermis (G).
Bars=50 µm (A and B), 100 µm (C, E and G), 15 µm (D and F).Tanaka et al. 170
group antigens or HMFG1, whereas other cells expressed
neither of these two antigens.
IV. Discussion
The eccrine ducts are sometimes histopathologically
indistinguishable from apocrine ducts and their tumors;
however, they are different in size, structure, distribution
and function. Therefore, there have been many studies to
differentiate them and their tumors [27, 28, 30]. To address
the issue, many immunohistochemical markers have been
found such as the 70 kDa glycoprotein purified from human
milk fat globule membrane (MFGM-gp 70) [15] and
HMFG1 [29]. Imam et al. reported that the antibody raised
against MFGM-gp 70 reacted with the apocrine glands, but
not with the eccrine glands [15]. de Viragh et al. also report-
ed the apocrine gland-specific expression of HMFG1 [29].
In this study, we immunostained skin samples with
mAb BA, mAb AR-1 and anti-HMFG1 in order to differen-
tiate between the apocrine and eccrine glands. A type 1/2
antigens and A type 3 antigens were detected by mAb BA
and mAb AR-1, respectively. We found that the duct cells
of the inner layer in normal eccrine glands expressed A type
1, 2 and 3 antigens regardless of the secretor status. On the
other hand, these antigens were expressed in the dark cells
of the eccrine glands from secretors, but not non-secretors.
These observations indicated that the dark cells of the ec-
crine glands expressed histo-blood group A type 1 and type
3 antigens, and that the duct cells expressed histo-blood
group A type 2 and type 3 antigens. This can be attributed
to the difference in the Se-gene dependency of each iso-type
of the histo-blood group antigens. The expression of type
1 antigens is under the control of the Se-gene, and the ex-
pression of type 2 antigens is independent of the Se-gene.
On the other hand, type 3 antigen expression can be either
dependent or independent of the Se-gene [3, 13]. Histo-
blood group antigens were not expressed in the apocrine
glands which expressed HMFG1 (Fig. 2C), suggesting
that histo-blood group antigens are good makers for distin-
guishing between normal eccrine glands and apocrine
glands.
Histo-blood group antigens can be found in various
normal cells, mainly of the epithelial type. In carcinomas,
the altered expression of various carbohydrate epitopes has
been observed. Detailed clinicopathological studies have
shown that differences in the survival rates of patients are re-
lated to the expression of histo-blood group antigens. Thus,
certain histo-blood group antigens are not simply tumor
markers, but may constitute part of the essential machinery
to induce metastasis and invasiveness. Nakagoe et al. [18,
19] reported the presence of histo-blood group antigens in
colorectal carcinomas, as well as the correlation between
histo-blood group antigens and a poor prognosis for the
patient. This is obvious in the distal colon, where histo-
blood group antigens are present up to the 10–14th week
of gestation; after that, they disappear for the remaining
period of postnatal life [8, 26]. They then reappear malig-
nantly transformed in the distal colon.
This study was conducted in order to differentiate
between apocrine and eccrine glands to further define of
their roles in EMPD. We used mAb BA and mAb AR-1 as
the specific markers for eccrine glands. Both mAbs strongly
reacted to the histo-blood group antigens in the EMPD.
However, since AR-1 did not react to the blood vessels, the
histo-blood group antigens in the tumor were detected more
clearly by AR-1 as compared to mAb BA. In our study, 7
out of 16 EMPD specimens were immunopositive for histo-
blood group A type 1, 2 and 3 antigens. Six out of 7 immuno-
positive cases were accompanied by dermal invasion. The
remaining immunopositive case was not accompanied by
dermal invasion, but was located at the right axilla and
genital region, which is termed multiple Paget’s disease.
This case was located in the axillary region. This case and
the two other of the 6 dermal invasion cases were accom-
panied by inguinal lymph node metastasis. In other words,
some of the neoplastic cells in EMPD express histo-blood
group antigens normally expressed in eccrine glands.
Furthermore, the histo-blood group antigen positive region
of EMPD did not express HMFG1. Some neoplastic cells
in EMPD expressed either histo-blood group antigens or
HMFG1, and other cells expressed neither of these two anti-
gens. The aberrant expression of histo-blood group anti-
gens in EMPD is similar to the oncodevelopmental antigens
expressed in colon carcinomas [19]. Although it is not
clear where the histo-blood group antigens are expressed
in the apocrine glands during the prenatal period, our data
suggest that re- or neo-expression of histo-blood group
antigens occurs in a continuous process.
In conclusion, histo-blood group antigens are specifi-
cally expressed in the eccrine glands, and therefore the ec-
crine glands can be distinguished from the apocrine glands
by the expression of histo-blood group antigens. We found
that EMPD accompanied by dermal invasion significantly
expressed histo-blood group antigens, as compared to
EMPD which did not have dermal invasion. Although addi-
tional investigation is required to elucidate the pathogenic
mechanisms responsible for the expression of histo-blood
group antigens in EMPD, these results suggest that the ex-
pression of histo-blood group antigens is related to a poor
histopathological prognosis of EMPD.
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